Tesamorelin — 20 mg

Tesamorelin 20 mg is a synthetic growth-hormone-releasing hormone (GHRH) analog studied for its ability to stimulate the body’s natural release of growth hormone. By activating GHRH receptors, tesamorelin supports research into growth hormone signaling, metabolic regulation, and body-composition pathways.

Tesamorelin has been clinically studied for its effects on visceral abdominal adipose tissue, making it a compound of interest in research focused on fat distribution, metabolic function, and growth hormone–mediated physiological processes. Researchers also investigate its potential effects on body composition and the downstream metabolic pathways associated with endogenous growth hormone activity.

Research Areas

• Growth Hormone Release: Research into stimulation of the body’s endogenous growth hormone secretion.
• GHRH Receptor Activity: Investigation of signaling pathways activated by GHRH receptor stimulation.
• Visceral Fat: Study of mechanisms affecting excess visceral abdominal adipose tissue.
• Body Composition: Research into changes in fat distribution and other measures of body composition.
• Metabolic Research: Exploration of growth hormone–related pathways involved in lipid and metabolic regulation.

FOR RESEARCH USE ONLY.